Identification and characterization of the molecular lesion causing mucopolysaccharidosis type I in cats

被引:37
|
作者
He, XX
Li, CM
Simonaro, CM
Wan, Q
Haskins, ME
Desnick, RJ
Schuchman, EH
机构
[1] CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA
[2] CUNY Mt Sinai Sch Med, Inst Gene Therapy & Mol Med, New York, NY 10029 USA
[3] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA
关键词
lysosomal storage diseases; animal models; mucopolysaccharidoses;
D O I
10.1006/mgme.1999.2860
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mucopolysaccharidosis Type I (MPS I) is the lysosomal storage disease caused by the deficient activity of alpha-L-iduronidase (IDUA). In man, MPS I can occur in severe, mild, or intermediate forms known as the Hurler, Scheie, or Hurler/Scheie syndromes, respectively. RIPS I also has been described in cats, dogs, and mice. This manuscript reports the identification and characterization of the mutation causing RIPS I in cats. To obtain wild-type feline IDUA cDNAs, two PCR-based strategies were used. PCR primers were constructed from a conserved region of the published human and dog sequences and used to amplify a 224-bp IDUA fragment from normal cat genomic DNA. This fragment was then used to screen a feline uterus cDNA library. PCR also was used to directly amplify IDUA fragments from the same cDNA library. Two overlapping feline IDUA cDNAs encoding 466 amino acid residues of the feline IDUA polypeptide (similar to 85% of the mature protein based on comparison to the human, dog, and mouse sequences) were obtained by these strategies. To identify the mutation causing NIPS I in cats, DNA sequencing was carried out on the corresponding IDUA region from several affected animals. A 3-bp deletion was found on both IDUA alleles in each of the MPS I animals, predicting the deletion of a single aspartate residue from the feline IDUA polypeptide. To confirm the authenticity of this mutation, heteroduplex, SSCP, and transient expression studies were carried out. Over 100 animals from the RIPS I colony were screened for the presence of the mutation by heteroduplex and SSCP analyses-in all cases the presence of the 3-bp deletion was 100% concordant with the disease phenotype. For transient expression studies, the two partial, overlapping feline cDNAs were combined and joined in-frame to the 5' end of the canine IDUA cDNA. This wild-type, hybrid cDNA expressed IDUA activity up to sixfold over endogenous levels after transfection into COS-1 cells. A modified full-length IDUA cDNA containing the 3-bp deletion did not express IDUA activity in a transient expression system, providing proof that this lesion was the cause of feline MPS I. (C) 1999 Academic Press.
引用
收藏
页码:106 / 112
页数:7
相关论文
共 50 条
  • [1] Molecular analysis of mucopolysaccharidosis type I in Morocco: Identification of novel mutation
    Sabir, Es-Said
    Najeh, Samira
    Lafhal, Karima
    Hammoud, Miloud
    Assiri, Imane
    Fdil, Naima
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [2] Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients
    Matte, U
    Yogalingam, G
    Brooks, D
    Leistner, S
    Schwartz, I
    Lima, L
    Norato, DY
    Brum, JM
    Beesley, C
    Winchester, B
    Giugliani, R
    Hopwood, JJ
    MOLECULAR GENETICS AND METABOLISM, 2003, 78 (01) : 37 - 43
  • [3] Clinical and Molecular Characterization of Patients with Mucopolysaccharidosis Type I in an Algerian Series
    Tebani, Abdellah
    Zanoutene-Cheriet, Lahouaria
    Adjtoutah, Zoubir
    Abily-Donval, Lenaig
    Brasse-Lagnel, Carole
    Laquerriere, Annie
    Marret, Stephane
    Benabdellah, Abla Chalabi
    Bekri, Soumeya
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (05)
  • [4] Mucopolysaccharidosis type I:: Identification and characterization of mutations affecting α-L-iduronidase activity
    Lee-Chen, GJ
    Lin, SP
    Chen, IS
    Chang, JH
    Yang, CW
    Chin, YW
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2002, 101 (06) : 425 - 428
  • [5] Identification and molecular characterization of α-L-iduronidase mutations present in mucopolysaccharidosis Type I patients undergoing enzyme replacement therapy
    Yogalingam, G
    Guo, XH
    Muller, VJ
    Brooks, DA
    Clements, P
    Kakkis, ED
    Hopwood, JJ
    HUMAN MUTATION, 2004, 24 (03) : 199 - 207
  • [6] Molecular Analysis of Vietnamese Patients with Mucopolysaccharidosis Type I
    Can, Ngoc Thi Bich
    Tran, Dien Minh
    Bui, Thao Phuong
    Nguyen, Khanh Ngoc
    Nguyen, Hoang Huy
    Nguyen, Tung Van
    Hwu, Wuh-Liang
    Tomatsu, Shunji
    Vu, Dung Chi
    LIFE-BASEL, 2021, 11 (11):
  • [7] Molecular analysis of mucopolysaccharidosis type I in Tunisia: identification of novel mutation and eight Novel polymorphisms
    Latifa Chkioua
    Souhir Khedhiri
    Asma Kassab
    Amina Bibi
    Salima Ferchichi
    Roseline Froissart
    Christine Vianey-Saban
    Sandrine Laradi
    Abdelhedi Miled
    Diagnostic Pathology, 6
  • [8] Characterization of joint disease in mucopolysaccharidosis type I mice
    de Oliveira, Patricia G.
    Baldo, Guilherme
    Mayer, Fabiana Q.
    Martinelli, Barbara
    Meurer, Luise
    Giugliani, Roberto
    Matte, Ursula
    Xavier, Ricardo M.
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2013, 94 (05) : 305 - 311
  • [9] Molecular analysis of mucopolysaccharidosis type I in Tunisia: identification of novel mutation and eight Novel polymorphisms
    Chkioua, Latifa
    Khedhiri, Souhir
    Kassab, Asma
    Bibi, Amina
    Ferchichi, Salima
    Froissart, Roseline
    Vianey-Saban, Christine
    Laradi, Sandrine
    Miled, Abdelhedi
    DIAGNOSTIC PATHOLOGY, 2011, 6
  • [10] Identification of a mutation causing mucopolysaccharidosis type IIIA in New Zealand Huntaway dogs
    Yogalingam, G
    Pollard, T
    Gliddon, B
    Jolly, RD
    Hopwood, JJ
    GENOMICS, 2002, 79 (02) : 150 - 153